Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

At Binghamton University, researchers were among the first to find ways to help patients with Duchenne muscular dystrophy ...

The parents of accused Chico library shooter Bradley Sayer fought over his access to guns during their bitter divorce battle, ...

Representative Thomas Kean Jr. announced he had been hospitalized for depression. More than one in four U.S. adults report ...

Most people believe that aging is synonymous with steadily losing cognitive and physical abilities — that the best older ...

Experts share warning signs to watch out for and how to prevent heat-related illnesses.

Over-the-air software updates have become a normal part of owning many modern vehicles, especially electric cars. They allow ...

My personal experiment with magnesium glycinate changed more than just my sleep ...

A growing form of donation is expanding the organ supply in the US — and testing how medicine protects dying patients.

Somewhere in the Mojave Desert, a gleaming white dome sits in the middle of nowhere, and the story behind it is stranger than ...

The police chief announced no criminal wrongdoing has been found regarding the planning of a now-dead data center project ...

A new study suggests a common brain protein may be enabling Alzheimer’s to spread between neurons through microscopic vesicles, revealing a potential new target for slowing disease progression. A ...